United States Clinical Microbiology Market 2025: Industry Developments, Future Growth, Share & Industry Insights | bioMérieux SA, Danaher Corporation, Becton, Dickinson and Company

Clinical microbiology market size was valued at USD 3.9 billion in 2022 and is estimated to reach USD billion by 2031, growing at a CAGR of 6.5% during the forecast period 2024-2031.

DataM Intelligence has published a new research report on "Clinical Microbiology Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/clinical-microbiology-market?sg

Key Players: bioMérieux SA, Danaher Corporation, Becton, Dickinson and Company, Abbott Laboratories, Bio-Rad Laboratories, Inc, F. Hoffmann-La Roche AG, Bruker Corporation, Hologic, Inc., QIAGEN N.V., Thermo Fisher Scientific Inc.

United States - Industry Latest News:

✅ CDC AI Diagnostics Initiative
In September 2025, the CDC funded new initiatives to strengthen microbiology labs and deploy AI-driven diagnostics for faster outbreak detection.

✅ Shionogi's Cefiderocol Data at IDWeek 2025
On October 21, 2025, Shionogi presented real-world evidence at IDWeek 2025, demonstrating improved clinical outcomes when cefiderocol is used as earlier treatment.

Japan - Industry Latest News:

✅ Tigermed Acquires Micron CRO
On July 29, 2025, Tigermed completed the acquisition of Japanese CRO Micron, enhancing its presence in Japan and Asia.

✅ Mérieux NutriSciences Acquires Bureau Veritas' Food Testing Activities
On February 3, 2025, Mérieux NutriSciences completed the acquisition of Bureau Veritas' food testing activities in Japan, expanding its portfolio.

South Korea - Industry Latest News:

✅ Esco Lifesciences Acquires Esco Korea Micro Ltd.
On September 20, 2024, Esco Lifesciences Group successfully acquired its distributor, Esco Korea Micro Ltd., through a newly formed subsidiary, Esco Lifesciences Korea Co., Ltd.

✅ Korea Lab 2025 Exhibition
Held from April 22-25, 2025, in Goyang, Korea, Korea Lab 2025 showcased advancements in clinical laboratory technology, including microbiology innovations.

Europe - Industry Latest News:

✅ ESCMID Global Congress 2025
From April 17-21, 2025, in Munich, Germany, ESCMID Global brought together experts in infectious diseases and clinical microbiology to exchange ideas and explore the latest innovations.

✅ Waters and BD's Biosciences & Diagnostic Solutions Business Merger
On July 14, 2025, Waters Corporation and BD announced a definitive agreement to combine BD's Biosciences & Diagnostic Solutions business with Waters, creating a leader in life science and diagnostics.

Growth Forecast Projected:

The Global Clinical Microbiology Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Clinical Microbiology Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=clinical-microbiology-market?sg

Key Segments:

By Product Type (Reagents, Laboratory Instruments, Automated Culture Systems)

By Application (Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Others)

By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Regional Analysis for Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Clinical Microbiology producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Clinical Microbiology revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/clinical-microbiology-market?sg

FAQ's

Q1: What is the current size of the Clinical Microbiology Market?

A: The Clinical Microbiology Market stood at USD 3.9 billion in 2022 and is set to experience remarkable growth, reaching USD billion by 2031

Q2: How fast is the Clinical Microbiology Market growing?

A: The Market is on an impressive growth trajectory, expected to expand at a CAGR of 6.5% from 2024-2031.

Have any Enquiry of This Report @ https://www.datamintelligence.com/enquiry/clinical-microbiology-market?sg

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.